AstraZeneca found in breach of industry code over Symbicort marketing, industry body saysReuters • 10/24/25
AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff ReprieveZacks Investment Research • 10/13/25
AstraZeneca's drug pricing deal with Trump far from clear result, say analystsProactive Investors • 10/13/25
AstraZeneca furthers ambition to redefine cancer care with first data from four major pivotal trials at ESMOBusiness Wire • 10/13/25
AstraZeneca Cuts Discounted Drug Pricing Deal With the White House. The Stock Is Rising.Barrons • 10/10/25
AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.Market Watch • 10/10/25
AstraZeneca is the latest major drugmaker to strike a deal with the Trump administration on lowering U.S. drug prices, according to a person familiar with the matterWSJ • 10/10/25
AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobsBusiness Wire • 10/09/25